Brief: Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
11/09/2025 12:45
Sept 11 (Reuters) - Maze Therapeutics Inc MAZE.O: MAZE THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $150.0 MILLION PRIVATE PLACEMENT MAZE THERAPEUTICS INC - PROCEEDS TO ADVANCE MZE829, INITIATE PHASE 2 TRIALS OF MZE782 Source text: ID:nGNX6pw6Qc Further company coverage: MAZE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maze Therapeutics
See all newsMaze Therapeutics rises after Citi initiates with 'buy'
Maze Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Maze Therapeutics Q2 net loss widens, misses estimates on higher R&D expenses
Maze Therapeutics posts smaller than expected Q1 loss
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway